Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 40 entries
Sorted by: Best Match Show Resources per page
Cephalosporin-induced Hemolytic Anemia in a Sicilian Child.

Hematology (Amsterdam, Netherlands)

Malaponte G, Arcidiacono C, Mazzarino C, Pelligra S, Li Volti G, Bevelacqua V, Li Volti S.
PMID: 27424561
Hematology. 2000;5(4):327-34. doi: 10.1080/10245332.2000.11746527.

A 27-month-old child developed acute hemolysis on two occasions after the administration of cephalosporin. On the first occasion, hemolysis was intravascular and was due to the formation of complexes between antibodies and the drug, which bound to red blood...

Cite
Malaponte G, Arcidiacono C, Mazzarino C, et al. Cephalosporin-induced Hemolytic Anemia in a Sicilian Child. Hematology. 2000;5(4):327-34doi: 10.1080/10245332.2000.11746527.
Malaponte, G., Arcidiacono, C., Mazzarino, C., Pelligra, S., Li Volti, G., Bevelacqua, V., & Li Volti, S. (2000). Cephalosporin-induced Hemolytic Anemia in a Sicilian Child. Hematology (Amsterdam, Netherlands), 5(4), 327-34. https://doi.org/10.1080/10245332.2000.11746527
Malaponte, G, et al. "Cephalosporin-induced Hemolytic Anemia in a Sicilian Child." Hematology (Amsterdam, Netherlands) vol. 5,4 (2000): 327-34. doi: https://doi.org/10.1080/10245332.2000.11746527
Malaponte G, Arcidiacono C, Mazzarino C, Pelligra S, Li Volti G, Bevelacqua V, Li Volti S. Cephalosporin-induced Hemolytic Anemia in a Sicilian Child. Hematology. 2000;5(4):327-34. doi: 10.1080/10245332.2000.11746527. PMID: 27424561.
Copy Download .nbib Format: NLM
Cephalosporin-induced Hemolytic Anemia in a Sicilian Child; Erythropoiesis.

Hematology (Amsterdam, Netherlands)

Malaponte G, Arcidiacono C, Mazzarino C, Pelligra S, Li Volti G, Bevelacqua V, Li Volti S.
PMID: 11399632
Hematology. 2000;5(4):327-334.

A 27-month-old child developed acute hemolysis on two occasions after the administration of cephalosporin. On the first occasion, hemolysis was intravascular and was due to the formation of complexes between antibodies and the drug, which bound to red blood...

Cite
Malaponte G, Arcidiacono C, Mazzarino C, et al. Cephalosporin-induced Hemolytic Anemia in a Sicilian Child; Erythropoiesis. Hematology. 2000;5(4):327-334
Malaponte, G., Arcidiacono, C., Mazzarino, C., Pelligra, S., Li Volti, G., Bevelacqua, V., & Li Volti, S. (2000). Cephalosporin-induced Hemolytic Anemia in a Sicilian Child; Erythropoiesis. Hematology (Amsterdam, Netherlands), 5(4), 327-334.
Malaponte, G., et al. "Cephalosporin-induced Hemolytic Anemia in a Sicilian Child; Erythropoiesis." Hematology (Amsterdam, Netherlands) vol. 5,4 (2000): 327-334.
Malaponte G, Arcidiacono C, Mazzarino C, Pelligra S, Li Volti G, Bevelacqua V, Li Volti S. Cephalosporin-induced Hemolytic Anemia in a Sicilian Child; Erythropoiesis. Hematology. 2000;5(4):327-334. PMID: 11399632.
Copy Download .nbib Format: NLM
THE MILITARY FAMILY: AN ASSET OR A LIABILITY.

Military medicine

RYAN FJ, BEVILACQUA JJ.
PMID: 14209543
Mil Med. 1964 Oct;129:956-9.

No abstract available.

Cite
RYAN FJ, BEVILACQUA JJ. THE MILITARY FAMILY: AN ASSET OR A LIABILITY. Mil Med. 1964;129:956-9
RYAN, F. J., & BEVILACQUA, J. J. (1964). THE MILITARY FAMILY: AN ASSET OR A LIABILITY. Military medicine, 129956-9.
RYAN, F J, and BEVILACQUA, J J. "THE MILITARY FAMILY: AN ASSET OR A LIABILITY." Military medicine vol. 129 (1964): 956-9.
RYAN FJ, BEVILACQUA JJ. THE MILITARY FAMILY: AN ASSET OR A LIABILITY. Mil Med. 1964 Oct;129:956-9. PMID: 14209543.
Copy Download .nbib Format: NLM
Tumor vascular disruption using various radiation types.

PeerJ

Bevelacqua J.
PMID: 24749005
PeerJ. 2014 Apr 01;2:e320. doi: 10.7717/peerj.320. eCollection 2014.

The feasibility of disrupting a tumor's vascular structure with various radiation types and radionuclides is investigated. Calculated absorbed dose profiles for photons and (4)He ions suggest that low-energy beta-gamma and alpha emitting radionuclides can deposit sufficient absorbed dose to...

Cite
Bevelacqua J. Tumor vascular disruption using various radiation types. PeerJ. 2014;2:e320doi: 10.7717/peerj.320.
Bevelacqua, J. (2014). Tumor vascular disruption using various radiation types. PeerJ, 2e320. https://doi.org/10.7717/peerj.320
Bevelacqua, Jj. "Tumor vascular disruption using various radiation types." PeerJ vol. 2 (2014): e320. doi: https://doi.org/10.7717/peerj.320
Bevelacqua J. Tumor vascular disruption using various radiation types. PeerJ. 2014 Apr 01;2:e320. doi: 10.7717/peerj.320. eCollection 2014. PMID: 24749005; PMCID: PMC3976121.
Copy Download .nbib Format: NLM
Progress towards Bait Station Integration into Oral Rabies Vaccination Programs in the United States: Field Trials in Massachusetts and Florida.

Tropical medicine and infectious disease

Bjorklund BM, Haley BS, Bevilacqua RJ, Chandler MD, Duffiney AG, von Hone KW, Slate D, Chipman RB, Martin A, Algeo TP.
PMID: 30270897
Trop Med Infect Dis. 2017 Aug 21;2(3). doi: 10.3390/tropicalmed2030040.

Bait stations for distribution of oral rabies vaccine baits are designed for rabies management in highly-developed areas where traditional distribution of oral rabies vaccine baits may be difficult. As part of national efforts to contain and eliminate the raccoon...

Cite
Bjorklund BM, Haley BS, Bevilacqua RJ, et al. Progress towards Bait Station Integration into Oral Rabies Vaccination Programs in the United States: Field Trials in Massachusetts and Florida. Trop Med Infect Dis. 2017;2(3)doi: 10.3390/tropicalmed2030040.
Bjorklund, B. M., Haley, B. S., Bevilacqua, R. J., Chandler, M. D., Duffiney, A. G., von Hone, K. W., Slate, D., Chipman, R. B., Martin, A., & Algeo, T. P. (2017). Progress towards Bait Station Integration into Oral Rabies Vaccination Programs in the United States: Field Trials in Massachusetts and Florida. Tropical medicine and infectious disease, 2(3), . https://doi.org/10.3390/tropicalmed2030040
Bjorklund, Brian M, et al. "Progress towards Bait Station Integration into Oral Rabies Vaccination Programs in the United States: Field Trials in Massachusetts and Florida." Tropical medicine and infectious disease vol. 2,3 (2017). doi: https://doi.org/10.3390/tropicalmed2030040
Bjorklund BM, Haley BS, Bevilacqua RJ, Chandler MD, Duffiney AG, von Hone KW, Slate D, Chipman RB, Martin A, Algeo TP. Progress towards Bait Station Integration into Oral Rabies Vaccination Programs in the United States: Field Trials in Massachusetts and Florida. Trop Med Infect Dis. 2017 Aug 21;2(3). doi: 10.3390/tropicalmed2030040. PMID: 30270897; PMCID: PMC6082100.
Copy Download .nbib Format: NLM
Congenital Myasthenic Syndrome due to .

European journal of translational myology

Bevilacqua JA, Lara M, Díaz J, Campero M, Vázquez J, Maselli RA.
PMID: 29118959
Eur J Transl Myol. 2017 Sep 20;27(3):6832. doi: 10.4081/ejtm.2017.6832. eCollection 2017 Jun 27.

Congenital myasthenic syndromes (CMS) are neuromuscular transmission disorders caused by mutations in genes encoding neuromuscular junction proteins. A 61-year-old female and her older sister showed bilateral ptosis, facial and proximal limb weakness, and scoliosis since childhood. Another female sibling...

Cite
Bevilacqua JA, Lara M, Díaz J, et al. Congenital Myasthenic Syndrome due to . Eur J Transl Myol. 2017;27(3):6832doi: 10.4081/ejtm.2017.6832.
Bevilacqua, J. A., Lara, M., Díaz, J., Campero, M., Vázquez, J., & Maselli, R. A. (2017). Congenital Myasthenic Syndrome due to . European journal of translational myology, 27(3), 6832. https://doi.org/10.4081/ejtm.2017.6832
Bevilacqua, Jorge A, et al. "Congenital Myasthenic Syndrome due to ." European journal of translational myology vol. 27,3 (2017): 6832. doi: https://doi.org/10.4081/ejtm.2017.6832
Bevilacqua JA, Lara M, Díaz J, Campero M, Vázquez J, Maselli RA. Congenital Myasthenic Syndrome due to . Eur J Transl Myol. 2017 Sep 20;27(3):6832. doi: 10.4081/ejtm.2017.6832. eCollection 2017 Jun 27. PMID: 29118959; PMCID: PMC5658635.
Copy Download .nbib Format: NLM
Commentary: Introduction to the Frontiers Research Topic: Optimization of Exercise Countermeasures for Human Space Flight-Lessons From Terrestrial Physiology and Operational Considerations.

Frontiers in physiology

Bevelacqua JJ, Welsh J, Mortazavi SMJ.
PMID: 31379613
Front Physiol. 2019 Jul 19;10:915. doi: 10.3389/fphys.2019.00915. eCollection 2019.

No abstract available.

Cite
Bevelacqua JJ, Welsh J, Mortazavi SMJ. Commentary: Introduction to the Frontiers Research Topic: Optimization of Exercise Countermeasures for Human Space Flight-Lessons From Terrestrial Physiology and Operational Considerations. Front Physiol. 2019;10:915doi: 10.3389/fphys.2019.00915.
Bevelacqua, J. J., Welsh, J., & Mortazavi, S. M. J. (2019). Commentary: Introduction to the Frontiers Research Topic: Optimization of Exercise Countermeasures for Human Space Flight-Lessons From Terrestrial Physiology and Operational Considerations. Frontiers in physiology, 10915. https://doi.org/10.3389/fphys.2019.00915
Bevelacqua, Joseph J, et al. "Commentary: Introduction to the Frontiers Research Topic: Optimization of Exercise Countermeasures for Human Space Flight-Lessons From Terrestrial Physiology and Operational Considerations." Frontiers in physiology vol. 10 (2019): 915. doi: https://doi.org/10.3389/fphys.2019.00915
Bevelacqua JJ, Welsh J, Mortazavi SMJ. Commentary: Introduction to the Frontiers Research Topic: Optimization of Exercise Countermeasures for Human Space Flight-Lessons From Terrestrial Physiology and Operational Considerations. Front Physiol. 2019 Jul 19;10:915. doi: 10.3389/fphys.2019.00915. eCollection 2019. PMID: 31379613; PMCID: PMC6659347.
Copy Download .nbib Format: NLM
Comments on Ahmad, I.M. et al. Healthcare Workers Occupationally Exposed to Ionizing Radiation Exhibit Altered Levels of Inflammatory Cytokines and Redox Parameters. .

Antioxidants (Basel, Switzerland)

Bevelacqua JJ, Mortazavi SMJ.
PMID: 30781403
Antioxidants (Basel). 2019 Feb 15;8(2). doi: 10.3390/antiox8020042.

This commentary is regarding the paper recently published by Ahmad et al [...].

Cite
Bevelacqua JJ, Mortazavi SMJ. Comments on Ahmad, I.M. et al. Healthcare Workers Occupationally Exposed to Ionizing Radiation Exhibit Altered Levels of Inflammatory Cytokines and Redox Parameters. . Antioxidants (Basel). 2019;8(2)doi: 10.3390/antiox8020042.
Bevelacqua, J. J., & Mortazavi, S. M. J. (2019). Comments on Ahmad, I.M. et al. Healthcare Workers Occupationally Exposed to Ionizing Radiation Exhibit Altered Levels of Inflammatory Cytokines and Redox Parameters. . Antioxidants (Basel, Switzerland), 8(2), . https://doi.org/10.3390/antiox8020042
Bevelacqua, Joseph J, and Mortazavi, Seyed Mohammad Javad. "Comments on Ahmad, I.M. et al. Healthcare Workers Occupationally Exposed to Ionizing Radiation Exhibit Altered Levels of Inflammatory Cytokines and Redox Parameters. ." Antioxidants (Basel, Switzerland) vol. 8,2 (2019). doi: https://doi.org/10.3390/antiox8020042
Bevelacqua JJ, Mortazavi SMJ. Comments on Ahmad, I.M. et al. Healthcare Workers Occupationally Exposed to Ionizing Radiation Exhibit Altered Levels of Inflammatory Cytokines and Redox Parameters. . Antioxidants (Basel). 2019 Feb 15;8(2). doi: 10.3390/antiox8020042. PMID: 30781403; PMCID: PMC6406610.
Copy Download .nbib Format: NLM
Comments on "Effects of partial- or whole-body exposures to .

Life sciences in space research

Bevelacqua JJ, Mortazavi S.
PMID: 34756223
Life Sci Space Res (Amst). 2020 Nov;27:105-106. doi: 10.1016/j.lssr.2020.08.002. Epub 2020 Aug 27.

No abstract available.

Cite
Bevelacqua JJ, Mortazavi S. Comments on "Effects of partial- or whole-body exposures to . Life Sci Space Res (Amst). 2020;27:105-106doi: 10.1016/j.lssr.2020.08.002.
Bevelacqua, J. J., & Mortazavi, S. (2020). Comments on "Effects of partial- or whole-body exposures to . Life sciences in space research, 27105-106. https://doi.org/10.1016/j.lssr.2020.08.002
Bevelacqua, Joseph J, and Mortazavi, Smj. "Comments on "Effects of partial- or whole-body exposures to ." Life sciences in space research vol. 27 (2020): 105-106. doi: https://doi.org/10.1016/j.lssr.2020.08.002
Bevelacqua JJ, Mortazavi S. Comments on "Effects of partial- or whole-body exposures to . Life Sci Space Res (Amst). 2020 Nov;27:105-106. doi: 10.1016/j.lssr.2020.08.002. Epub 2020 Aug 27. PMID: 34756223.
Copy Download .nbib Format: NLM
Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients.

Journal of biomedical physics & engineering

H A, I S, J J B, A J, A R, H Z, S A R M, S M J M.
PMID: 32802787
J Biomed Phys Eng. 2020 Aug 01;10(4):387-394. doi: 10.31661/jbpe.v0i0.2006-1125. eCollection 2020 Aug.

Physicians and scientists around the world are aggressively attempting to develop effective treatment strategies. The treatment goal is to reduce the fatality rate in 15% to 20% of individuals infected with SARS-CoV-2 who develop severe inflammatory conditions that can...

Cite
H A, I S, J J B, et al. Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients. J Biomed Phys Eng. 2020;10(4):387-394doi: 10.31661/jbpe.v0i0.2006-1125.
H, A., I, S., J J, B., A, J., A, R., H, Z., S A R, M., & S M J, M. (2020). Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients. Journal of biomedical physics & engineering, 10(4), 387-394. https://doi.org/10.31661/jbpe.v0i0.2006-1125
H, Abdollahi, et al. "Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients." Journal of biomedical physics & engineering vol. 10,4 (2020): 387-394. doi: https://doi.org/10.31661/jbpe.v0i0.2006-1125
H A, I S, J J B, A J, A R, H Z, S A R M, S M J M. Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients. J Biomed Phys Eng. 2020 Aug 01;10(4):387-394. doi: 10.31661/jbpe.v0i0.2006-1125. eCollection 2020 Aug. PMID: 32802787; PMCID: PMC7416097.
Copy Download .nbib Format: NLM
COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations.

Journal of biomedical physics & engineering

A R M, J J B, S A R M, S M J M.
PMID: 32637368
J Biomed Phys Eng. 2020 Jun 01;10(3):247-250. doi: 10.31661/jbpe.v0i0.2005-1114. eCollection 2020 Jun.

No abstract available.

Cite
A R M, J J B, S A R M, et al. COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations. J Biomed Phys Eng. 2020;10(3):247-250doi: 10.31661/jbpe.v0i0.2005-1114.
A R, M., J J, B., S A R, M., & S M J, M. (2020). COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations. Journal of biomedical physics & engineering, 10(3), 247-250. https://doi.org/10.31661/jbpe.v0i0.2005-1114
A R, Mehdizadeh, et al. "COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations." Journal of biomedical physics & engineering vol. 10,3 (2020): 247-250. doi: https://doi.org/10.31661/jbpe.v0i0.2005-1114
A R M, J J B, S A R M, S M J M. COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn't Induce Selective Pressure and New Mutations. J Biomed Phys Eng. 2020 Jun 01;10(3):247-250. doi: 10.31661/jbpe.v0i0.2005-1114. eCollection 2020 Jun. PMID: 32637368; PMCID: PMC7321390.
Copy Download .nbib Format: NLM
Comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India".

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Ghaznavi H, Bevelacqua JJ, Mortazavi SAR, Mortazavi SMJ, Welsh JS.
PMID: 34896158
Radiother Oncol. 2021 Dec 08; doi: 10.1016/j.radonc.2021.12.002. Epub 2021 Dec 08.

No abstract available.

Cite
Ghaznavi H, Bevelacqua JJ, Mortazavi SAR, et al. Comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India". Radiother Oncol. 2021;doi: 10.1016/j.radonc.2021.12.002.
Ghaznavi, H., Bevelacqua, J. J., Mortazavi, S. A. R., Mortazavi, S. M. J., & Welsh, J. S. (2021). Comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India". Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, . https://doi.org/10.1016/j.radonc.2021.12.002
Ghaznavi, Hamid, et al. "Comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India"." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology vol. (2021). doi: https://doi.org/10.1016/j.radonc.2021.12.002
Ghaznavi H, Bevelacqua JJ, Mortazavi SAR, Mortazavi SMJ, Welsh JS. Comments on "Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India". Radiother Oncol. 2021 Dec 08; doi: 10.1016/j.radonc.2021.12.002. Epub 2021 Dec 08. PMID: 34896158; PMCID: PMC8653397.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 40 entries